国邦医药 (605507.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(国邦医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 4,053,476,803.522,809,720,242.621,410,162,706.265,720,924,721.914,113,348,595.702,703,468,710.181,176,098,332.11
 营业收入(元) 4,053,476,803.522,809,720,242.621,410,162,706.265,720,924,721.914,113,348,595.702,703,468,710.181,176,098,332.11
二、营业总成本(元) 3,478,553,568.832,375,838,982.961,179,880,936.984,664,769,236.603,284,254,518.762,128,079,763.76928,813,541.43
 营业成本(元) 3,054,170,655.222,117,473,724.271,034,901,453.524,144,882,072.642,945,939,930.191,903,109,558.16810,636,030.07
 研发费用(元) 162,761,109.2297,438,359.9746,857,324.22197,542,261.42135,060,342.4986,607,056.3531,655,326.74
 营业税金及附加(元) 23,117,921.0216,493,811.158,031,212.9633,093,448.5622,377,645.4712,831,300.645,646,205.12
 销售费用(元) 53,851,258.6232,491,692.1615,342,074.0164,153,597.7239,150,135.9125,700,121.5814,791,829.37
 管理费用(元) 229,549,906.85152,448,229.1376,323,518.00293,108,997.44209,278,659.96127,480,561.1165,252,836.36
 财务费用(元) -44,897,282.10-40,506,833.72-1,574,645.73-68,011,141.18-67,552,195.26-27,648,834.08831,313.77
  其中:利息费用(元) 18,200,731.369,485,790.215,265,693.9616,547,864.3913,000,834.664,614,911.732,115,522.90
  其中:利息收入(元) 41,476,064.2529,867,621.9616,499,300.3129,364,135.2717,367,592.667,286,174.373,032,772.22
三、其他经营收益
 加:公允价值变动收益(元) -3,637,513.71-4,558,309.04---
 加:投资收益(元) 4,671,446.73-1,444,517.192,314,159.2819,536,570.9119,069,417.2712,554,419.466,011,137.92
  其中:对联营企业和合营企业的投资收益(元) -1,530,730.45-287,314.01-408,832.42-744,628.04-871,483.86-785,451.95-502,899.83
 资产处置收益(元) ---44.63---
 资产减值损失(元) -1,246,964.88-17,017,810.39-1,021,249.44-27,706,467.40-9,785,681.04-7,943,839.23-7,901,607.78
 信用减值损失(元) -19,809,511.65-4,719,172.39-2,603,054.38-12,501,910.91-5,162,666.29-7,105,205.43-8,368,322.34
 其他收益(元) 5,437,632.573,178,694.471,578,936.5812,835,768.867,117,017.375,725,306.072,561,109.00
四、营业利润(元) 563,975,837.46417,515,967.87230,550,561.321,052,877,800.44840,332,164.25578,619,627.29239,587,107.48
 加:营业外收入(元) 2,117,052.74377,857.10226,151.52562,611.27928,597.25585,880.41326,467.58
 减:营业外支出(元) 6,542,328.404,987,703.762,143,683.2317,801,048.8110,824,639.8511,070,133.264,810,266.35
五、利润总额(元) 559,550,561.80412,906,121.21228,633,029.611,035,639,362.90830,436,121.65568,135,374.44235,103,308.71
 减:所得税费用(元) 71,894,822.2956,049,758.1633,661,674.14115,017,300.03109,079,846.8873,140,342.1434,796,545.82
六、净利润(元) 487,655,739.51356,856,363.05194,971,355.47920,622,062.87721,356,274.77494,995,032.30200,306,762.89
(一)按经营持续性分类
  持续经营净利润(元) 487,655,739.51356,856,363.05194,971,355.47920,622,062.87721,356,274.77494,995,032.30200,306,762.89
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 489,073,265.39357,470,775.26194,629,337.80920,904,230.12721,064,644.06495,038,347.85200,394,843.05
  少数股东损益(元) -1,417,525.88-614,412.21342,017.67-282,167.25291,630.71-43,315.55-88,080.16
 扣除非经常性损益后的净利润(元) 483,445,930.56357,850,586.20192,025,631.09906,710,272.68708,397,141.87489,031,219.87197,294,973.30
七、每股收益
 一、基本每股收益(元) 0.880.640.351.651.290.890.36
 二、稀释每股收益(元) 0.880.640.351.651.290.890.36
九、综合收益总额(元) 487,655,739.51356,856,363.05194,971,355.47920,622,062.87721,356,274.77494,995,032.30200,306,762.89
 归属于母公司所有者的综合收益总额(元) 489,073,265.39357,470,775.26194,629,337.80920,904,230.12721,064,644.06495,038,347.85200,394,843.05
 归属于少数股东的综合收益总额(元) -1,417,525.88-614,412.21342,017.67-282,167.25291,630.71-43,315.55-88,080.16
公告日期 2023-10-192023-07-292023-04-152023-04-152022-10-192022-08-202022-04-28
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院